Diversified Healthcare Trust (NASDAQ: DHC) stock: the official figures
Diversified Healthcare Trust (DIVERSIFIED HEALTHCARE TRUST) is listed on Nasdaq under the ticker DHC and belongs to the real estate sector. In fiscal 2025 it reported revenue of $1,538m and a net loss of $285.9m, according to the annual accounts it filed with the regulator.
Identifiers for Diversified Healthcare Trust: SEC CIK 1075415.
Fiscal 2025 figures
| Item | 2025 | 2024 | Change |
|---|---|---|---|
| Revenue | $1,538m | $1,495m | +2.8% |
| Operating profit | −$116.4m | −$136.1m | — |
| Net profit | −$285.9m | −$370.3m | — |
| Earnings per share | −$1.19 | −$1.55 | — |
| Operating margin | −7.6% | −9.1% | +1.5 pts |
| Net margin | −18.6% | −24.8% | +6.2 pts |
| Total assets | $4,361m | $5,137m | −15.1% |
| Equity | $1,666m | $1,959m | −15.0% |
| Cash | $105.4m | $144.6m | −27.1% |
| Operating cash flow | −$19.6m | $112.2m | −117.5% |
Margins are calculated from the filed figures: operating profit and net profit over revenue.
10 fiscal years
| Fiscal year | Revenue | Operating profit | Net profit | Earnings per share | Document |
|---|---|---|---|---|---|
| 2025 | $1,538m | −$116.4m | −$285.9m | −$1.19 | Annual report |
| 2024 | $1,495m | −$136.1m | −$370.3m | −$1.55 | Annual report |
| 2023 | $1,410m | −$80.9m | −$293.6m | −$1.23 | Annual report |
| 2022 | $1,284m | $188.3m | −$15.8m | −$0.07 | Annual report |
| 2021 | $1,383m | $437.1m | $174.5m | $0.73 | Annual report |
| 2020 | $1,632m | $68.4m | −$139.5m | −$0.59 | Annual report |
| 2019 | $1,040m | $97.3m | −$88.2m | −$0.37 | Annual report |
| 2018 | $1,117m | $471.7m | $286.9m | — | Annual report |
| 2017 | $1,075m | $275.2m | $147.6m | — | Annual report |
| 2016 | $1,058m | $303.1m | $141.3m | — | Annual report |
The full income statement, balance sheet and cash flow statement are in the annual accounts of Diversified Healthcare Trust. Year by year: dividends paid. Purchases and sales by its executives and directors are in insider transactions.
Dividends
In fiscal 2025, Diversified Healthcare Trust paid $9.7m in dividends, according to its cash flow statement.
| Fiscal year | Dividends paid | Share of net profit |
|---|---|---|
| 2025 | $9.7m | — |
| 2024 | $9.6m | — |
| 2023 | $9.6m | — |
| 2022 | $9.6m | — |
| 2021 | $9.5m | 5.5% |
| 2020 | $42.8m | — |
| 2019 | $199.7m | — |
| 2018 | $370.7m | 129.2% |
| 2017 | $370.6m | 251.1% |
| 2016 | $370.5m | 262.2% |
Cash paid out as dividends during the fiscal year, including dividends to minority shareholders of subsidiaries when the company does not report them separately. It is not the dividend per share.
Frequently asked questions about Diversified Healthcare Trust
- How much did Diversified Healthcare Trust earn in fiscal 2025?
- Diversified Healthcare Trust reported a net loss of $285.9m for fiscal 2025, on revenue of $1,538m. The year before it reported a net loss of $370.3m.
- Does Diversified Healthcare Trust pay a dividend?
- In fiscal 2025, Diversified Healthcare Trust paid $9.7m in dividends, according to its cash flow statement.
- What are the earnings per share of Diversified Healthcare Trust?
- They were −$1.19 in fiscal 2025, compared with −$1.55 the year before.
- Where is Diversified Healthcare Trust listed?
- Diversified Healthcare Trust is listed on Nasdaq under the ticker DHC and belongs to the real estate sector.
- Where do the figures for Diversified Healthcare Trust come from?
- From the annual report (Form 10-K) that Diversified Healthcare Trust files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
The annual accounts come from the annual report (Form 10-K) that Diversified Healthcare Trust files with the SEC, the US securities regulator. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.